Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy

References

• Ali I. Nano anti-cancer drugs: pros and cons and future perspectives. Curr Cancer Drug Targets, 2011;11:131–4.
   PubMed Web of Science ®Google Scholar
• Ali I, Aboul-Enein HY, Ghanem A. Enantioselective toxicity and carcinogenesis. Curr Pharm Anal, 2005;1:109–25.
   Web of Science ®Google Scholar
• Ali I, Nadeem Lone M, Al-Othman Z, Al-Warthan A, Marsin Sanagi M. Heterocyclic scaffolds: Centrality in anticancer drug development. Curr Cancer Drug Targets, 2015;16:711–34.
   Web of Science ®Google Scholar
• Ali I, Salim K, Rather MA, Wani WA, Haque A. Advances in nano drugs for cancer chemotherapy. Curr Cancer Drug Targets, 2011;11:135–46.
   PubMed Web of Science ®Google Scholar
• Arnold L, Dagan A, Gutheil J, Kaplan N. Antineoplastic activity of poly (L-lysine) with some ascites tumor cells. Proc Natl Acad Sci, 1979;76:3246–50.
   PubMed Web of Science ®Google Scholar
• Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 1996;17:93–102.
   PubMed Web of Science ®Google Scholar
• Ciapetti G, Cenni E, Pratelli L, Pizzoferrato A. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials, 1993;14:359–64.
   PubMed Web of Science ®Google Scholar
• Chew SA, Hinojosa VA, Arriaga MA. 2017. 11 - Bioresorbable polymer microparticles in the medical and pharmaceutical fields. Bioresorbable Polymers for Biomedical Applications. UK: Woodhead Publishing, 229–264. ISBN: 978-0-08-100262-9
   Google Scholar
• De Tayrac R, Chentouf S, Garreau H, Braud C, Guiraud I, Boudeville P, Vert M. In vitro degradation and in vivo biocompatibility of poly (lactic acid) mesh for soft tissue reinforcement in vaginal surgery. J Biomed Mater Res B Appl Biomater, 2008;85:529–36.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M. 2012. GLOBOCAN, cancer incidence and mortality worldwide: IARC cancer base no. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
   Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015;136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• ISO I. 2009. 10993-05: biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity. ISO 10993-12: 2007. International Organization for Standardization.
   Google Scholar
• Jamshidian M, Tehrany EA, Imran M, Jacquot M, Desobry S. Poly‐lactic acid: Production, applications, nanocomposites, and release studies. Compr Rev Food Sci Food Safety, 2010;9:552–71.
   PubMed Web of Science ®Google Scholar
• Joye IJ, Mcclements DJ. Biopolymer-based nanoparticles and microparticles: Fabrication, characterization, and application. Curr Opin Colloid Interf Sci, 2014;19:417–27.
   Web of Science ®Google Scholar
• Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly (L-lysine)-poly (ethylene glycol)-folate conjugate. Langmuir, 2005;21:8852–7.
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerf, 2010;75:1–18.
   PubMed Web of Science ®Google Scholar
• Laemmli U. Characterization of DNA condensates induced by poly (ethylene oxide) and polylysine. Proc Natl Acad Sci USA, 1975;72:4288–92.
   PubMed Web of Science ®Google Scholar
• Leo E, Ruozi B, Tosi G, Vandelli MA. PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated. Int J Pharm, 2006;323:131–8.
   PubMed Web of Science ®Google Scholar
• Mantripragada VP, Jayasuriya AC. Effect of dual delivery of antibiotics (vancomycin and cefazolin) and BMP-7 from chitosan microparticles on Staphylococcus epidermidis and pre-osteoblasts in vitro. Mater Sci Eng C, 2016;67:409–17.
   PubMed Web of Science ®Google Scholar
• Moghe A, Gupta B. Co‐axial electrospinning for nanofiber structures: Preparation and applications. Polymer Rev, 2008;48:353–77.
   Web of Science ®Google Scholar
• Obayemi J, Danyuo Y, Dozie-Nwachukwu S, Odusanya O, Anuku N, Malatesta K, Yu W, Uhrich K, Soboyejo W. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability. Mater Sci Eng C, 2016;66:51–65.
   PubMed Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev, 2003;55:403–19.
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Rasal RM, Janorkar AV, Hirt DE. Poly (lactic acid) modifications. Progress Polym Sci, 2010;35:338–56.
   Web of Science ®Google Scholar
• Rozenberg M, Shoham G. FTIR spectra of solid poly-l-lysine in the stretching NH mode range. Biophys Chem, 2007;125:166–71.
   PubMed Web of Science ®Google Scholar
• Saini P, Arora M, Kumar MR. Poly (lactic acid) blends in biomedical applications. Adv Drug Deliv Rev, 2016;107:47–59.
   PubMed Web of Science ®Google Scholar
• Saleem K, Wani WA, Haque A, Malhotra A, Ali I. Nanodrugs: Magic bullets in cancer chemotherapy. Topics Anti Cancer Res, 2013;58:437–94.
   Google Scholar
• Shan X, Yuan Y, Liu C, Xu F, Sheng Y. Comparison of the PLA-mPEG and mPEG-PLA-mPEG copolymers nanoparticles on the plasma protein adsorption and in vivo biodistribution. Soft Matter, 2009;5:2875–83.
   Web of Science ®Google Scholar
• Shukla SC, Singh A, Pandey AK, Mishra A. Review on production and medical applications of ɛ-polylysine. Biochem Eng J, 2012;65:70–81.
   Web of Science ®Google Scholar
• Szende B, Szökán G, Tyihá E, Pál K, Gáborjányi R, Almás M, Khlafulla A. Antitumor effect of lysine-isopeptides. Cancer Cell Int, 2002;2:1.
   PubMedGoogle Scholar
• Tait SW, Green DR. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol, 2010;11:621–32.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (USFDA). 2011. Inventory of effective food contact substance (FCS) notifications. FCN no. 1018.
   Google Scholar
• Wang DK, Varanasi S, Fredericks PM, Hill DJ, Symons AL, Whittaker AK, Rasoul F. FT‐IR characterization and hydrolysis of PLA‐PEG‐PLA based copolyester hydrogels with short PLA segments and a cytocompatibility study. J Polym Sci A Poly Chem, 2013;51:5163–76.
   Web of Science ®Google Scholar
• World Health Organization. 2014. Cancer Fact sheet N 297. February 2014.
   Google Scholar
• Wu F-LL, Yeh T-H, Chen Y-L, Chiu Y-C, Cheng J-C, Wei M-F, Shen L-J. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Mol Pharm, 2014;11:2777–86.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Nagasaki Y, Kato Y, Sugiyama Y, Kataoka K. Long-circulating poly (ethylene glycol)–poly (D, L-lactide) block copolymer micelles with modulated surface charge. J Control Release, 2001;77:27–38.
   PubMed Web of Science ®Google Scholar
• Yeh T-H, Chen Y-R, Chen S-Y, Shen W-C, Ann DK, Zaro JL, Shen L-J. Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Mol Pharm, 2015;13:262–71.
   PubMed Web of Science ®Google Scholar